Biotech | May 02, 2022
Xcardia announces first-in-human use of its new Xtractor device
The announcement follows FDA 510(k) clearance of device
The announcement follows FDA 510(k) clearance of device
CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes
As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies
Avacc 3 has significant advantages over existing whooping cough vaccines
CLNK is a biotechnology research and development company that utilizes umbilical cord blood as the raw material to develop innovative, allogeneic, off-the-shelf, cell based therapeutic products
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim
The plant is expected to start commercial operations from Q4FY24
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
Subscribe To Our Newsletter & Stay Updated
